Pharmaron
Pharmaron appears in 1 markets tracked by Meridian Consensus across 1 industry (Healthcare). Aggregate market exposure is $15M, computed as the sum of (share × market size) across every appearance.
Its strongest position is Radioactive Isotope Labeling Services Market at 3.1% share in a market growing at 5.7% CAGR. Average share across all tracked markets is 3.1%, indicating a meaningful incumbent presence.
Each market page below carries the full Porter Five Forces, SWOT, regional sub-data, regulatory landscape, and competitor table the operator competes against. Use the related-operator rail at the bottom of the page to triangulate Pharmaron against the peers it actually overlaps with in those segments.
Market positions
Avg share 3.1% · sorted by exposure| Market | Market size | Share | Exposure |
|---|---|---|---|
| Radioactive Isotope Labeling Services Market | $485M | 3.1% |
Explore adjacent markets
Each market page surfaces Porter Five Forces, SWOT, country analysis, patent filings, regulatory signals, and more, verified against SEC filings, FRED macro series, and trade-association benchmarks.
Operators that compete with Pharmaron
Peers that show up alongside Pharmaron in the markets above. Ordered by how many overlapping markets they share, the top of the list is who the operator competes against most directly.